The 6 th course is scheduled October 15-23, 2022

AMR eNews | The Canadian Anti-infective Innovation Network (CAIN)

Diseases once easily treated with antibiotics are spreading across the globe and threatening the lives of millions, producing chronic health conditions, and costing the healthcare industry billions. The Canadian Anti-infective Innovation Network (CAIN) was formed with the purpose of leveraging Canada’s innovative approaches and expertise to solve the expanding health crisis caused by antimicrobial resistance […]

AMR eNews | The Canadian Anti-infective Innovation Network (CAIN) Read More »

Uppsala University

Uppsala Antibiotic Center

Uppsala Antibiotic Center (UAC) is a new center for research, education, innovation & awareness that was founded by Vice-Chancellor Eva Åkesson in 2015 to bring together, stimulate and support important research on antibiotic resistance from all three disciplinary domains at Uppsala University: Medicine and Pharmacy, Science and Technology, and Humanities and Social Sciences.

Uppsala Antibiotic Center Read More »

Antibiotic Resistance | The Center For Disease Dynamics, Economics & Policy (CDDEP)

To better communicate the problem of antimicrobial resistance (AMR), researchers at The Center For Disease Dynamics, Economics & Policy (CDDEP) developed the Drug Resistance Index (DRI), which provides a snapshot of the effectiveness of antibiotic therapy by country. The DRI resembles stock market indices and combines antibiotic consumption measurements with resistance data to help compare […]

Antibiotic Resistance | The Center For Disease Dynamics, Economics & Policy (CDDEP) Read More »

The Global Antibiotic Research and Development Partnership (GARDP)

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization developing new treatments for drug-resistant infections that pose the greatest threat to health. GARDP works with partners to ensure sustainable access to treatments, promoting responsible use and affordability to all in need. Learn more on the GARDP website.

The Global Antibiotic Research and Development Partnership (GARDP) Read More »

Antibiotic Resistance Project | The Pew Charitable Trusts

Antibiotics are one of the greatest success stories in modern medicine. Although we associate them with treating acute infections, these drugs underpin much of health care—from routine surgical procedures to organ transplants and cancer treatment. Unfortunately, the history of antibiotics is a race between innovation and resistance. As innovative science furnishes novel drugs, bacterial evolution […]

Antibiotic Resistance Project | The Pew Charitable Trusts Read More »

CARB-X: Combatting Antibiotic Resistance Bacteria

CARB-X is accelerating global antibacterial innovation by investing in the development of new antibiotics and other life-saving products to combat the most dangerous drug-resistant bacteria. Their projects represent the world’s largest pre-clinical and early development pipeline of antibiotics and other therapeutics, diagnostics, microbiome and vaccines. Since CARB-X was established in July 2016, it has invested […]

CARB-X: Combatting Antibiotic Resistance Bacteria Read More »

Wellcome Trust

Drug-resistant infections kill hundreds of thousands of people every year, in all parts of the world. This burden is disproportionately higher in low- and middle-income countries. If we act now, we can turn the tide on antimicrobial resistance (AMR), save millions of lives and safeguard the medical progress of the past hundred years for future […]

Wellcome Trust Read More »

Scroll to Top